Arena Pharmaceuticals (ARNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2006 | 12-2005 | 12-2004 | 12-2003 | 12-2002 | |
| Sales | 30,569 | 23,233 | 13,686 | 12,834 | 19,422 |
| Gross Profit | 30,569 | 23,233 | 13,686 | 12,834 | 19,422 |
| Operating Expenses | 123,391 | 94,369 | 71,470 | 64,297 | 55,749 |
| Operating Income | -92,822 | -71,136 | -57,784 | -51,462 | -36,328 |
| Interest Expense | 1,838 | 1,838 | 1,854 | 37 | 77 |
| Other Income | 8,412 | 5,073 | 1,646 | 4,440 | 3,574 |
| Pre-tax Income | -86,248 | -67,901 | -57,992 | -47,059 | -32,830 |
| Net Income Continuous | -86,248 | -67,901 | -57,992 | -47,059 | -32,830 |
| Net Income | $-86,248 | $-67,901 | $-57,992 | $-47,059 | $-32,830 |
| EPS Basic Total Ops | -18.90 | -22.40 | -24.00 | -17.40 | -11.90 |
| EPS Basic Continuous Ops | -18.45 | -19.75 | -22.72 | -17.33 | -11.94 |
| EPS Diluted Total Ops | -18.90 | -22.40 | -24.00 | -17.40 | -11.90 |
| EPS Diluted Continuous Ops | -18.45 | -19.75 | -22.72 | -17.33 | -11.94 |
| EBITDA(a) | $-84,641 | $-62,157 | $-46,092 | $-39,193 | $-27,546 |